pharmaceutical investing European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
pharmaceutical investing Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
pharmaceutical investing Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU
pharmaceutical investing Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
pharmaceutical investing Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
pharmaceutical investing U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
pharmaceutical investing Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
pharmaceutical investing Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
pharmaceutical investing Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
pharmaceutical investing Pantera Minerals Limited High-Grade Antimony to 3.9% Sb and Extensive Soil Anomalies Confirm Priority Drill Targets
